Overall rank by patents
#20,119
of 50,000 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 14 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Nanjing ranks #20,119 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 14 technology areas.
USPTO PatentsView assignee plate
Corpus R20119 · Foreign Corporation #20,119 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Multi-color Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Nanjing DRUM Tower H… · this assignee
48 score
3D Lighting Innovati… · lowest
7 score
What this shows Nanjing DRUM Tower Hospital stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-PAR, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #20,119 of 50,000; Innovation Score 47.7/100 sits in the top 18% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Multi-color Corporation (±0 grants).
Nanjing DRUM Tower Hospital has been granted 14 US utility patents between 2022 and 2025, placing Nanjing DRUM Tower Hospital at #20,119 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Nanjing DRUM Tower Hospital is one of the more focused assignees in the PatentsView dataset. By volume, Nanjing sits between Multi-color Corporation (14 patents, rank #20,111) and Nantong T-SUN NEW Energy Co., Ltd. (14 patents, rank #20,119) - the closest US assignees by grant volume. The composite Innovation Score of 47.7/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2022 through 2025, with 14 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Nanjing DRUM Tower Hospital's 8.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 14 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Multi-Color Corporation
14 patents
Multiquip Inc.
14 patents
NAC International Inc.
14 patents
NAKAMURA-TOME PRECISION INDUSTRY CO., LTD.
14 patents
NANOBACTERIE
14 patents
NANOGRID LIMITED
14 patents
NANOWEAR INC.
14 patents
NANTONG T-SUN NEW ENERGY CO., LTD.
14 patents
NANJING DRUM TOWER HOSPITAL
14 patents
What this shows Nanjing holds 14 patents at rank #20,115, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,115 in granted patent volume.
Other assignees with the most granted patents in Nanjing's primary technology class.
Nanjing's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 2 | 14.3% |
| 2023 | 1 | 7.1% |
| 2024 | 2 | 14.3% |
| 2025partial year | 9 | 64.3% |
Top 14 of 14 technology areas
Overall rank by patents
#20,119
of 50,000 tracked assignees
47.7 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.